Active, Not Recruiting
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)
NCT05710666
- Conditions
- HER2-positive Breast Cancer
- Locations
-
- University Hospital Galway Galway, Connacht, Ireland
- Saint Vincent's University Hospital Dublin, Leinster, Ireland
- Beaumont Hospital Dublin, Leinster, Ireland
- Cork University Hospital Cork, Munster, Ireland